PCRX – pacira biosciences, inc. (US:NASDAQ)
Stock Stats
News
4/11
08:55 am
pcrx
Medium
Pacira BioSciences (NASDAQ:PCRX) stock falls 4.1% in past week as three-year earnings and shareholder returns continue downward trend [Yahoo! Finance]
4/9
08:09 am
pcrx
Low
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $45.00 price target on the stock.
4/2
08:00 am
pcrx
Low
Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
3/14
09:40 am
pcrx
Low
Pacira's (PCRX) Knee Osteoarthritis Drug Gets FDA's RMAT Tag [Yahoo! Finance]
3/13
07:16 am
pcrx
Medium
Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the Knee [Yahoo! Finance]
2/29/2024
08:00 am
PCRX
-0.7%
BEAT
11/2/2023
08:00 am
PCRX
6.0%
MISS
8/2/2023
08:00 am
PCRX
2.0%
BEAT
5/3/2023
08:00 am
PCRX
-7.2%
BEAT
4/9
08:09 am
Reiterates
Buy
Buy
Needham & Company LLC
Low
2.9%
4/9
06:15 am
Reiterates
Buy
Buy
Needham
Low
2.9%
4/9
06:15 am
Reiterates
Buy
Buy
Needham
Low
2.9%
3/7
08:02 am
Reiterates
Overweight
JPMorgan Chase & Co.
Low
0.8%
3/7
05:00 am
Assumes
Overweight
JP Morgan
Low
0.8%
4/22
04:21 pm
pcrx
Low
Form ARS Pacira BioSciences, Inc. For: Dec 31
4/22
04:20 pm
pcrx
Low
Form DEF 14A Pacira BioSciences, Inc. For: Jun 11
4/22
04:18 pm
pcrx
Medium
Form DEFA14A Pacira BioSciences, Inc.
3/8
05:34 pm
pcrx
Low
Form 4 Pacira BioSciences, Inc. For: Mar 06 Filed by: PACE GARY W
2/29
05:33 pm
pcrx
Low
Form S-8 Pacira BioSciences, Inc.
Show more
Top News Gainers
4/17 Pacira Biosciences Inc (NASDAQ: PCRX) had its "buy" rating re-affirmed by analysts at Northland Securities. They now have a $50.00 price target on the stock. 13.0%
3/23 Pacira Biosciences Inc (NASDAQ: PCRX) had its price target lowered by analysts at Piper Sandler from to . 6.6%
3/12 Form 4 Pacira BioSciences, Inc. For: Mar 11 Filed by: WINSTON ROY 6.0%
10/3 Pacira Biosciences Inc (NASDAQ: PCRX) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 5.7%
2/10 Form SC 13G/A Pacira BioSciences, Inc. Filed by: BlackRock Inc. 5.0%
6/6 Form 4 Pacira BioSciences, Inc. For: Jun 05 Filed by: Brege Laura 4.6%
4/30 Pacira to Report First Quarter 2020 Financial Results on Thursday May 7, 2020 4.5%
4/24 Form DEF 14A Pacira BioSciences, Inc. For: Jun 08 3.6%
3/17 Pacira Biosciences Inc (NASDAQ: PCRX) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. 3.5%
11/7 Pacira Biosciences Inc (NASDAQ: PCRX) had its "hold" rating re-affirmed by analysts at Cowen Inc. They now have a $41.00 price target on the stock. 3.3%
Top News Decliners
3/20 Pacira Biosciences Inc (NASDAQ: PCRX) was upgraded by analysts at SVB Leerink LLC from a "market perform" rating to an "outperform" rating. -12.1%
3/23 Pacira Biosciences Inc (NASDAQ: PCRX) had its price target lowered by analysts at Royal Bank of Canada from $65.00 to $56.00. They now have an "outperform" rating on the stock. -9.6%
3/9 Pacira BioSciences to Present at the 2020 Barclays Global Healthcare Conference -6.8%
2/20 Pacira Biosciences Inc (NASDAQ: PCRX) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -3.6%
8/8 Q2/2019 6/30/2019 EPS 0.410 ZacksConsensus 0.140 ActVsEst 0.270 - Beat -3.4%
9/24 Pacira BioSciences Set to Join S&P SmallCap 600 -3.3%
6/5 Form 4 Pacira BioSciences, Inc. For: Jun 03 Filed by: Scranton Richard -3.2%
2/21 Form 10-K Pacira BioSciences, Inc. For: Dec 31 -3.1%
9/30 Form SC 13G Pacira BioSciences, Inc. Filed by: INTEGRATED CORE STRATEGIES (US) LLC -3.0%
1/7 EXPAREL Achieves Primary and Key Secondary Endpoints in Phase 4 CHOICE Study in Cesarean Section Patients -2.9%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3